Presentation TCT 2017 Poland Presents: Case Conclusion - How I Treated This Case Presenter: Petr Kala, Jochen Wöhrle, Dariusz Dudek October 30, 2017
Presentation TCT 2017 Czech Republic Comments: How Would I Treat This Case and Why? Presenter: Petr Kala, Jochen Wöhrle, Marian Branny October 30, 2017
Presentation TCT 2017 Poland Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis Presenter: Petr Kala, Jochen Wöhrle, Dariusz Dudek October 30, 2017
Presentation TCT 2017 Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes Presenter: Petr Kala, Jochen Wöhrle, Martin Hudec October 30, 2017
Presentation TCT 2017 Noninvasive Detection of Coronary Artery Disease Using Resting Phase Signals and Advanced Machine Learning Presenter: Bernard De Bruyne, Evelyn S. Regar, Thomas D. Stuckey October 30, 2017
Presentation TCT 2017 Coronary Artery Disease: Pathology and Pathogenesis Presenter: Grzegorz L. Kaluza, Jose M. Wiley October 29, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Conference News TCT 2016 TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES Michael O'Riordan November 02, 2016
Presentation TCT 2016 TCT 517: Fractional Flow Reserve Assessment of Coronary Artery Disease in Patients Undergoing TAVI. Presenter: Alan C. Yeung, Tim P. van de Hoef November 01, 2016
Presentation TCT 2016 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI Presenter: David P. Faxon, C. Michael Gibson, Deepak L. Bhatt November 01, 2016
Presentation TCT 2016 When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy? Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran November 01, 2016
Presentation TCT 2016 Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding Presenter: David P. Faxon, C. Michael Gibson November 01, 2016
Presentation TCT 2016 General Overview and Highlights of the North American Consensus Document on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI Presenter: David P. Faxon, C. Michael Gibson, Dominick J. Angiolillo November 01, 2016
Presentation TCT 2016 European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI Presenter: David P. Faxon, C. Michael Gibson, Davide Capodanno November 01, 2016
Presentation TCT 2016 What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT Presenter: David P. Faxon, C. Michael Gibson, Freek W.A. Verheugt November 01, 2016
Presentation TCT 2016 The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT Presenter: David P. Faxon, C. Michael Gibson, Christopher B. Granger November 01, 2016
News Conference News TCT 2016 ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 COLOR: A Prospective, Multicenter Registry Evaluating the Relationship Between Lipid-Rich Plaque and Two-Year Outcomes After Stent Implantation in Patients With Coronary Artery Disease Presenter: Howard C. Herrmann, Robert J. de Winter, Giora Weisz November 01, 2016
News Conference News TCT 2016 New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts Yael L. Maxwell October 31, 2016
Presentation TCT 2016 Trends in Outcomes of Treatment for LM Artery Disease: IRIS-MAIN Registry Data (N=5,020) Presenter: Seung-Jung Park, Alan C. Yeung October 31, 2016